0000876661-13-000744.txt : 20131002
0000876661-13-000744.hdr.sgml : 20131002
20131002152831
ACCESSION NUMBER: 0000876661-13-000744
CONFORMED SUBMISSION TYPE: 25-NSE/A
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20131002
DATE AS OF CHANGE: 20131002
EFFECTIVENESS DATE: 20131002
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Actavis, Inc.
CENTRAL INDEX KEY: 0000884629
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 953872914
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13305
FILM NUMBER: 131130036
BUSINESS ADDRESS:
STREET 1: MORRIS CORPORATE CENTER III
STREET 2: 400 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 9092701400
MAIL ADDRESS:
STREET 1: MORRIS CORPORATE CENTER III
STREET 2: 400 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
FORMER COMPANY:
FORMER CONFORMED NAME: WATSON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930513
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NEW YORK STOCK EXCHANGE LLC
CENTRAL INDEX KEY: 0000876661
IRS NUMBER: 000000000
STATE OF INCORPORATION: NY
FILING VALUES:
FORM TYPE: 25-NSE/A
BUSINESS ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-656-2060
MAIL ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
FORMER COMPANY:
FORMER CONFORMED NAME: NEW YORK STOCK EXCHANGE INC
DATE OF NAME CHANGE: 19910628
25-NSE/A
1
primary_doc.xml
X0203
0000876661
NEW YORK STOCK EXCHANGE LLC
884629
Actavis, Inc.
001-13305
Morris Corporate Center III
400 Interpace Parkway
Parsippany
NJ
NEW JERSEY
07054
862.261.7000
Common Stock
17 CFR 240.12d2-2(a)(3)
Paras Madho
Director
2013-10-02
EX-99.25
2
ruleprovisionnotice.htm
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES
The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on October 14, 2013, pursuant to the provisions of Rule 12d2-2 (a).
[ X ] 17 CFR 240.12d2-2(a)(3) That on October 1, 2013 the instruments representing the securities comprising the entire class of this security came to evidence, by operation of law or otherwise, other securities in substitution therefore and represent no other right except, if such be the fact, the right to receive an immediate cash payment.
The acquisition by Actavis plc of Actavis, Inc. and Warner Chilcott Public Limited Company (Nasdaq 'WCRX') became effective on October 1, 2013. Each share of (Old) Common Stock of Warner Chilcott Public Limited Company was converted into 0.160 of a (New) Ordinary Share of Actavis plc for each Ordinary Share of Warner Chilcott Public Limited Company held. Each share of (Old) Common Stock of Actavis Inc. was exchanged for a (New) Ordinary Share of Actavis plc on a share to share basis.
The Exchange also notifies the Securities and Exchange Commission that as a result of the above indicated conditions this security was suspended from trading on October 1, 2013.